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Abstract
Background: Podocytes are highly specialized epithelial cells on the visceral side of the glomerulus. Their interdigitating
primary and secondary foot processes contain an actin based contractile apparatus that can adjust to changes in the
glomerular perfusion pressure. Thus, the dynamic regulation of actin bundles in the foot processes is critical for
maintenance of a well functioning glomerular filtration barrier. Since the actin binding protein, cofilin-1, plays a significant
role in the regulation of actin dynamics, we examined its role in podocytes to determine the impact of cofilin-1 dysfunction
on glomerular filtration.
Methods and Findings: We evaluated zebrafish pronephros function by dextran clearance and structure by TEM in cofilin-1
morphant and mutant zebrafish and we found that cofilin-1 deficiency led to foot process effacement and proteinuria. In
vitro studies in murine and human podocytes revealed that PMA stimulation induced activation of cofilin-1, whereas
treatment with TGF-b resulted in cofilin-1 inactivation. Silencing of cofilin-1 led to an accumulation of F-actin fibers and
significantly decreased podocyte migration ability. When we analyzed normal and diseased murine and human glomerular
tissues to determine cofilin-1 localization and activity in podocytes, we found that in normal kidney tissues
unphosphorylated, active cofilin-1 was distributed throughout the cell. However, in glomerular diseases that affect
podocytes, cofilin-1 was inactivated by phosphorylation and observed in the nucleus.
Conclusions: Based on these in vitro and in vivo studies we concluded cofilin-1 is an essential regulator for actin filament
recycling that is required for the dynamic nature of podocyte foot processes. Therefore, we describe a novel
pathomechanism of proteinuria development.
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Introduction
Podocytes are highly specialized epithelial cells covering the
visceral side of the glomerular capillary. They consist of a cell body
that gives rise to major processes and minor foot processes (FPs)
that are anchored to the glomerular basement membrane via
integrins at the focal contact sites. The FPs of neighboring cells
form a branched interdigitating network and are interconnected
by a multiprotein complex that covers the spaces between the FPs
and the slit diaphragms (SD) [1]. The SD is the final barrier for
high molecular weight molecules preventing their loss in the
glomerular filtrate. The focal contacts as well as the SD are
functionally linked to the actin cytoskeletal backbone of the foot
process, making actin the common denominator of podocyte
function [2].
Podocyte foot process effacement is commonly observed in a
large variety of glomerular diseases associated with proteinuria [3].
The pathophysiological basis of podocyte effacement is the
reorganization of the actin cytoskeletal backbone of the foot
process. The characteristic parallel contractile actin bundles found
in the podocyte reorganize into dense actin networks which results
in loss of the normal interdigitating pattern, dysfunctional filtration
slits and the development of proteinuria [4]. Since foot process
effacement is a reversible process, it is critical to understand the
molecular mechanisms underlying these structural changes and
effacement as well as recovery would require an orchestrated
reorganization of actin filaments [5]. A variety of genetic
alterations of podocyte proteins indirectly lead to an aberrant
cytoskeletal structure, indicating a sensitive signaling balance that
can be influenced by mechanical as well as cytokine based signals
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12626[6–9]. Thus far, mutations in the a-actinin-4 gene are the only
known genetic alterations related to the actin cytoskeleton that
lead to a podocyte phenotype similar to progressive glomerulo-
sclerosis in humans. The five identified, distinct point mutations in
the head-domains of the a-actinin protein, all mediate increased
actin cross-linking [10–12]. In this study we wanted to examine the
role of the actin depolymerizing factor (ADF)/cofilin (AC) family
of proteins in podocytes. The AC family of proteins binds both
globular (G-Actin) and filamentous actin (F-actin) and this binding
is regulated by multiple mechanisms: phosphorylation, interaction
with polyphosphoinositides, pH, and competitive binding interac-
tions with other actin binding proteins [13,14]. When cofilin
becomes phosphorylated by the kinases, LIMK1/2 or TESK, on
serine 3, cofilin can no longer bind F-actin or G-actin [15]. The
phosphatases, slingshot and chronophin, dephosphorylate and
activate cofilin [16]. These regulatory elements strictly control the
ability of cofilin to bind actin through upstream signaling cascades
in response to activation of receptor tyrosine kinases (RTKs) and
integrins and through regulating each other [14]. Once activated,
cofilin at lower concentrations binds to F-actin and induces a twist
in the filament which weakens the actin-to-actin attachments and
results in filament severing. At higher cofilin concentrations, cofilin
decorates the filaments and appears to enhance Pi release from
actin monomers within the filament, to increase actin treadmilling
and actin depolymerization from the filament pointed end [17].
In this manuscript we found that cofilin was required for normal
glomerular filtration in morphant and mutant zebrafish. We
demonstrated uncharacteristic actin reorganization and podocyte
migration behavior in vitro in the absence of cofilin-1 and we found
aberrant cofilin-1 activation in diseased human tissues.
Methods
Ethics Statement
Animal work was conducted according to the guidelines of the
American Physiologic Society and was approved by Institutional
Animal Care and Use Committee of the Mount Desert Island
Biological Laboratory, Maine (IACUC protocol #0804). All
efforts were made to minimize the number of animals used and
their suffering.
Clinical renal biopsy samples
Renal tissue was obtained from the archives of the Department
of Cellular Pathology, John Radcliffe Hospital, Oxford. Paraffin-
embedded specimens of normal kidney from nephrectomies
performed for tumour, and renal biopsy samples from adults with
primary focal segmental glomerulosclerosis (FSGS), minimal
change disease (MCD) and idiopathic membranous nephropathy
(MN) were included in this study. All patients with renal disease
had nephrotic-range proteinuria at the time of biopsy. Ethics
approval was obtained from the Oxford Research Ethics
Committee B (Reference #C02.062) for use of human tissue. All
patients gave written consent at hospital admission to experiments
on their anonymized archived tissue samples.
Zebrafish stocks, injections and functional assays
Zebrafish (AB) were mated and grown at 28.5uC in embryo
rearing media (E3) as previously described in [18]. Using the
Nanoject II injection device (Drummond Scientific, Broomall,
PA), cofilin-1 and scrambled control morpholinos were injected
into one to four-cell stage fertilized embryos at 100 mM
concentrations in 4.6 nl injection buffer (20 mM Hepes,
200 mM KCl and 0.01% phenol red). Morpholino sequences
were designed and ordered from GeneTools (Philomath, OR) as
follows: standard control sequence - 59-CCTCTTACCTCAGT-
TACAATTTATA-39 and cofilin-1 sequence – 59-TTGAAT-
GAGCTGTGATGCAGTCCCT-39. For glomerular function
studies, 48 hours post fertilization (hpf) dechorionated embryos
were anesthetized with a 1:20 to 1:100 dilution of 4 mg/ml
Tricaine (MESAB: ethyl-3-aminobenzoate, methanesulfonate acid
salt, 1% Na2HPO4, pH 7.0) (Sigma-Aldrich) and placed in a 1.2%
agarose mold for injection. The embryos were then injected either
with 70-kDa rhodamine-labeled or FITC-labeled dextrans into the
cardiac venous sinus (Molecular Probes, Eugene, OR). Immedi-
ately after injection, the embryos were placed in 200 ml ERM in
single wells of 96 well plates and allowed to recover. For
observation of rhodamine-labeled dextran passing the glomerular
barrier, we used the Wt1b-GFP transgenic zebrafish line [19]
which was a gift from Christoph Englert, Jena. Fluorescent FITC-
dextran clearance from the pupil of the embryo eye was measured
in AB-wildtype embryos and evaluated as previously described in
Hentschel et al. [18]. The animal protocol was approved by the
Mount Desert Island Biological Laboratory (MDIBL) Animal
Care Committee. Cofilin-1 mutant embryos, obtained from the
Zebrafish International Research Center (ZIRC), were the result
of mating wildtype AB female zebrafish with sperm from an AB
zebrafish heterozygous for the hi3736aTg proviral insertion in the
cfl1 gene [20]. These embryos were grown to six months of age
and then mated with AB wildtype zebrafish in the University of
Maine zebrafish facility (IACUC protocol #A2008-2-07). Hetero-
zygous zebrafish resulting from this mating were confirmed by
PCR and mated to spawn cofilin-1 mutant fish.
Transmission Electron Microscopy (TEM)
Both morphant and mutant larval zebrafish were sampled at
120 hpf and fixed in 1.5% glutaraldehyde/1% PFA and 70 mM
NaPO4, pH 7.2. After fixation the embryos were washed three
times in 0.2 M cacodylate buffer and then postfixed in 1% osmium
tetroxide for one hour at room temperature. After rinsing with
cacodylate buffer all specimens were dehydrated in a graded
ethanol series and infiltrated and embedded with epon according
to manufacturer’s protocol (Hard Plus Resin 812, Electronmicro-
scopy Sciences, Hatfield, PA). Ultra-thin (80–100 nm, thick)
sections of the kidney were cut using a Leica Rotary Microtome
and mounted on slot and 300 mesh grids (Luxel, Friday Harbor,
WA). The sections were stained with 2% uranyl acetate in distilled
water, and contrasted with lead citrate. Sections were viewed and
photographed on a JEOL-1230 Transmission Electron Micro-
scope (Eching,Germany).
Podocyte Culture
Murine podocytes were cultured in RPMI-1640 cell medium
(Biochrom) containing 10% FBS, penicillin/streptomycin and
IFNc (10 U/ml) at 33uC with 5% CO2 on type 1 collagen coated
flasks as previously described [21]. Immortalized human podo-
cytes (gift from Moin Saleem, Bristol) were grown in RPMI-1640
cell medium (Biochrom) containing 10% FBS, penicillin/strepto-
mycin and insulin-transferrin-sodium selenite (ITS) at 33uC with
5% CO2 as previously described [22]. Both podocytes cell lines
were grown on plastic and incubated at 37uC with 5% CO2 for a
minimum of 10 days to differentiate.
Protein Extraction and Western Blot Procedure
Protein from differentiated podocytes was extracted in lysis
buffer (RIPA Buffer: 0.6 g Tris in 100 mL ddH2O, pH 7.5, 0.88 g
NaCl, 0.1 g SDS, 0.5 g NaDeoxycloate, 1.0 g NP-40 Tergitol),
100 ml 100 mM NaVO4, 500ml 1 M NaF, and 1 Complete Mini
Protease Inhibitor Cocktail Tablet (Roche Scientific) combined
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for 1 hour, centrifuged at 4uC for 15 minutes at 11,000 rpm and
the supernatant was recovered. Protein concentration was
determined with the Bicinchoninic Acid (BCA) Protein Assay
using the Sunrise TECAN plate reader and XRead Plus Software.
SDS-PAGE and Western analysis were performed on 10 mgo r
20 mg of these podocyte extracts. Western blots were probed with
primary antibodies, p-cofilin (1:1000) (Santa Cruz) or cofilin-1
(1:5000) (Cytoskeleton) followed by the HRP labeled goat anti-
rabbit secondary antibody (1:10,000) (Santa Cruz). The PIERCE
Chemiluminesence kit was used to detect the HRP labeled
antibodies with Celtic SMR Ltd Cronex 5 film. The samples were
normalized using GAPDH primary antibody (Santa Cruz).
For time course stimulations, cells were incubated in starvation
media (supplemented RPMI media except with 1% FBS overnight
at 37uC). The following morning media containing the stimulating
agents, PMA (2mM) and TGF-b (5 ng/ml), was added to the cells.
At each desired time point, cells were harvested and protein
extractions were prepared.
Quantitative PCR analysis
Total RNA was prepared from human glomeruli and cultivated
human or murine podocytes using the RNeasyHMiniKit (Qiagen,
Hilden, Germany) following the protocol recommended by the
manufacturer with an additional step of DNAse digestion (RNase-
Free DNase Set; Qiagen). One microgram of total RNA was
reverse transcribed using Oligo (dT) 15 and random primers and
M-MLV Reverse Transcriptase (Promega, Mannheim, Germany).
Quantitative PCR (qPCR) was performed on a Light Cycler 480
(Roche, Mannheim, Germany). The cDNA was amplified using
Fast Start Taq Polymerase (Roche Diagnostics, Mannheim
Germany), SYBR Green (Molecular probes, Eugene, OR), gene
specific primers and the following PCR conditions: 5 min at 95uC,
45 cycles for 10 s at 95uC, 10 s at 60uC and 10 s at 72uC.
Specificity of the amplification product was verified by melting
curve analysis. The samples were measured as multiplexed
reactions and normalized to the constitutive gene human
Hypoxanthin-Phosphoribosyl Transferase 1 (HPRT-1).
All primers for the listed transcripts were designed using
Primer3 software:
mADF left: CGA AGG ATG CCA TCA AG; mADF right:
GGT CCG ATT GAG GTC TTC; hADF left: CTA TGC AAG
CTC CAA GGA; hADF right: CTG GTC CAT TTG CTT
GAC; mCofilin-1 left: CAA GGA TGC CAT CAA GAA;
mCofilin-1 right: GTC CTT GAC CTC CTC GTA; hCofilin-1
left: TTT ATG CCA GCT CCA AGG AC; hCofilin-1 right:
GCT TGA TCC CTG TCA GCT TC; mCofilin-2 left: TGC
TAG CTC TAA AGA TGC CAT T; mCofilin-2 right: AGC
CAT TTA ACT TGC CAC TCA; hCofilin-2 left: TGC TAG
CTC TAA AGA TGC CAT T; hCofilin-2 right: CAA GCC ATT
TAC TTG CCA CTC.
Histology
Paraffin embedded murine and human tissue slides were
deparaffinized following a standard protocol. After washing and
blocking, the tissues were incubated in primary antibodies to
cofilin-1 (1:25), p-cofilin (1:100) and synaptopodin antibody
(undiluted tissue culture supernatant) or podocalyxin antibody
(1:50). The tissues were then incubated either with Cy3-labeled
donkey anti-rabbit or FITC-labeled goat anti-mouse or Alexa-488
labeled donkey anti- rabbit secondary antibodies. Nuclei were
visualized using a DAPI counter stain. Images were taken using a
Zeiss Axioplan-2 imaging microscope with the digital image-
processing program AxioVision 4.3 (Zeiss, Jena, Germany).
Cofilin-1 Silencing
Murine podocytes were grown overnight at 33uC with IFNc.
The following day RPMI-1640 media without penicillin/strepto-
mycin was added. The podocytes were transfected with cofilin-1
and control siRNA (Santa Cruz Biotechnology Inc., Santa Cruz,
CA), using Lipofectamine 2000 Reagent (Invitrogen). The cofilin-1
specific duplex siRNAs purchased from Santa Cruz contain a pool
of 3 target-specific 19–25 nt siRNAs designed to knock down gene
expression. After silencing, the podocytes were grown for 72 hrs in
regular medium under non-permissive conditions at 37uC.
Cytochalasin D (20mM) was applied to disrupt the actin network
organization for 30 minutes at 37uC. After several washes with
PBS, the cells were recovered in RPMI media for 0, 1 hr, 2 hr and
8 hr time points. The podocytes then were fixed, blocked and
stained with FITC-labeled phalloidin and DAPI and mounted for
microscopy. For the cell wound-healing assay, the cells were grown
to confluency and a wound was applied using a sterile pipette tip.
Images were taken of identical regions after wounding and
24 hours later. The wound area was quantified using ImageJ
Software.
Actin polymerization assay
The Polymerization Biochem Kit was obtained from Cytoskel-
eton, Inc. (Denver, CO). The podocytes were lyzed in lysis buffer
(50 mM Tris (pH 7,5), 150 mM NaCl, 0,1% SDS, 0,5% Na-
Deoxycholate, 1% Nonidet p-40/tergitol). 30 mg cell extract was
mixed with actin polymerization buffer (50 mM KCl, 10 mM Tris
(pH 7.5), 1 mM MgCl2, 1 mM ATP). After addition of pyrene-
labelled actin (0.5 mM), fluorescence was measured every 30
seconds at 22uC in a spectrophotometer (excitation wavelength:
365 nm and emission wavelength: 407 nm).
Results
Loss of cofilin-1 induced foot process effacement and
proteinuria in zebrafish
To test the effects of cofilin-1 deficiency in vivo, zebrafish cofilin-
1 mutants and morpholino induced knockdowns were analyzed.
We found mutation of the cofilin-1 gene or knockdown of cofilin-1
expression resulted in severe edema in larval zebrafish. Mutant
(Fig. 1b) and morphant (Fig. 1c) zebrafish, reared to 120 hour post
fertilization showed consistent phenotypes. They both display
edema around the yolk, pericardial effusion, no swim bladder,
smaller eyes, arched backs and altered jaw features compared to
the wildtype embryos (Fig. 1a). On Western blots we confirmed
that cofilin-1 protein was significantly down regulated in
morpholino injected fish (data not shown). To test whether the
edematous phenotype was based on a disturbance of the
glomerular filtration barrier, we applied different functional assays
in live zebrafish embryos to examine leakiness of the filter to high
molecular weight proteins. In figure 1, panels d–j, we used the
Wt1b transgenic zebrafish [23] that displays green fluorescence in
the fused glomeruli as well as in the proximal tubules of the
pronephros (Fig. 1, panel e and h). We injected fertilized eggs with
control (Fig. 1, panels d–f) and cofilin-1 morpholinos (Fig. 1,
panels g–i) to produce morphants that expressed GFP in the
pronephros. These morphants and controls were then injected
with a 70 kDa rhodamine labeled dextran at 72 hpf into the
cardinal vein (Fig. 1, panels d and g). After injection we imaged the
pronephros 48 hours later (see merged images Fig. 1, g/g9 and i/i9).
In Wt1b control embryos, no rhodamine labeled dextran was
visible within the GFP-labeled proximal tubule region of the
pronephros (Fig. 1, panel f9). In contrast, the morphant prone-
phros was leaky for the high molecular weight dextran and the
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proximal tubular cells of the morphants (Fig. 1, panel i9). In
panels j, j9 and j0 the XZ reconstruction of the proximal tubules
with localization of rhodamine labeled dextran within the GFP
labeled tubular cells is depicted. These studies demonstrated
exemplarily in a morphant fish that cofilin-1 deficiency led to
disruption of barrier function of the glomerular filter. To
demonstrate and reproduce these studies in a larger variety of
embryos and to include the mutant in the analysis, we applied a
different functional test. We measured loss of intravascular
fluorescence activity using an eye assay that we established
previously [18]. This assay enables us to measure leakiness of
the glomerular filtration barrier as a rapid screening tool in
individual morphant and mutant fish. When we monitored
FITC-fluorescence activity in retinal blood vessels of individual
zebrafish, we found stable or increasing fluorescence activity
over a 24 hours period in wildtype or control morpholinos
injected embryos (wildtype mean =113%623, n=33; control
morpholino mean =139%629, n=25). Some embryos even
showed an increase in fluorescence activity due to better
intravascular distribution over time, in contrast, zebrafish
injected with cofilin-1 morpholinos and cofilin mutants exhibited
Figure 1. Knockdown of cofilin-1 expression by both morpholino silencing and viral insertional mutagenesis resulted in altered
zebrafish phenotypes, compromised glomerular filtration and podocyte effacement. The phenotype of mutant (b) and morphant (c)
embryos were compared to wildtype zebrafish embryos at 120 hpf (a). The mutant and morphant embryos had several aberrant features including
edema around the yolk, pericardial effusion, smaller eyes, an arched back, jaw malformation and an absent swim bladder. Control Wt1b-GFP
transgenic zebrafish (d–f, d9–f9) and those treated with cofilin-1 morpholinos (g–i, g9–i9) were injected with 70 kDa rhodamine labeled dextrans at
72 hpf and their pronephros imaged 48 hours later. The rhodamine labeled dextrans remained within the circulatory system of the Wt1b-GFP
zebrafish with no labeling within the Wt1b-GFP pronephros tubules (d–f, d9–f9). In contrast, in the Wt1b-GFP transgenic morphant embryos (g–i, g9–
i9), the vasculature was labeled by the rhodamine labeled dextran, but labeling was also observed within the pronephros tubules (magnification
=1806). (j–j0) XZ cross section of the collected optical stacks clearly demonstrated the intracellular localization of rhodamine labeled dextrans within
the pronephros tubules (yellow). (k) Functional studies demonstrated loss of pronephros function in cofilin-1 knockdown zebrafish embryos. Images
of intravascular fluorescence were captured in retinal blood vessels and monitored in individual fish over 24 hours in control, cofilin-1 mutant
zebrafish and zebrafish treated with 100mM cofilin-1 morpholinos. At forty-eight hours post injection of FITC-labeled 70 kDa dextrans into the
vascular system, the fluorescence intensity in the pupil of the zebrafish increased in wildtype embryos, but decreased in zebrafish treated with
100 mM cofilin-1 morpholinos and cofilin-1 mutants. (l) TEM analysis of podocytes in control, cofilin-1 mutant and cofilin-1 morpholino treated
zebrafish demonstrated severe podocyte effacement in cofilin-1 knockdown embryos. While wildtype (upper left) and control morpholino injected
(lower left) zebrafish embryos have normal foot processes and slit diaphragm formation, the cofilin-1 mutants (upper right) as well as the cofilin-1
morpholino injected fish (lower right) display foot process fusion and foot process effacement over large areas (size bar: 500 nm).
doi:10.1371/journal.pone.0012626.g001
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(cofilin morpholino mean =24%614, n=17; cofilin mutant
mean =62%617, n=24; p,0.001 control and wildtype vs.
morpholino and mutant) (Fig. 1, panel k). To determine if the
structural integrity of podocytes was compromised in the cofilin-
1 morphant and mutant embryos, we analyzed glomeruli of
120 hpf embryos by transmission electron microscopy. Podocyte
effacement was observed in both cofilin-1 morphant and mutant
fishes whereas in control fish podocyte foot processes and slit
diaphragms were clearly visible (Fig. 1, panel l). These data
indicate that cofilin-1 is an indispensable factor for the integrity
of normal podocyte foot processes in zebrafish.
Cofilin-1 is expressed in murine and human podocytes
Normal murine and human kidney tissues were probed with
antibodies to cofilin and synaptopodin, a podocyte specific marker,
to demonstrate cofilin-1 localized to podocytes in vivo. These
studies confirmed localization of cofilin-1 along with synaptopodin
in murine and human podocytes (Fig. 2A, white arrowheads). In
murine tissue slides, cofilin-1 expression was also visible in
synaptopodin negative glomerular cells, whereas cofilin-1 expres-
sion was primarily restricted to podocytes in human glomeruli.
Using Q-PCR experiments, we examined undifferentiated and
differentiated murine and human cultured podocytes to determine
the expression levels of the actin depolymerizing factor/cofilin
(AC) family. We determined cofilin-1 mRNA was expressed at
least three times more than the ADF-isoform in murine podocytes
and ten times more than ADF in human podocytes (Fig. 2B). As
expected, expression of the muscle specific isoform cofilin-2 was
negligible in both podocyte species. When we compared
undifferentiated (proliferating) and differentiated (non-proliferat-
ing) murine and human podocytes, we found expression of cofilin-
1 and ADF was only slightly increased in both species at the
differentiated state. These results suggested the predominant AC-
isoform in podocytes is cofilin-1.
Cofilin-1 activity is altered in response to TGF-b and PMA
in vitro
To determine the regulation of cofilin-1 activity in podocytes,
we analyzed phosphorylation profiles in differentiated murine and
human cultured podocytes in vitro in response to different stimuli.
Interestingly, we could already detect baseline phosphorylation of
cofilin-1 in both species (Fig. 3A). When we analyzed cofilin-1
phosphorylation in response to the known podocyte stressor, TGF-
b, we found that in both murine and human species TGF-b
stimulation led to increased cofilin-1 phosphorylation and reduced
cofilin-1 activity. In contrast, when we stimulated podocytes with
phorbol 12-myristate 13-acetate (PMA), which is often used as an
activating phorbol ester of protein kinase C (PKC), we could
document a significant dephosphorylation of cofilin-1 in both
murine and human podocytes (Fig. 3A and B). This is consistant
with several reports describing PKC activation as a known
regulator of actin cytoskeletal dynamics in various cell types [24].
These data indicate that cofilin-1 phosphorylation can be
regulated in podocytes in response to extracellular stimuli in both
directions leading to an increase or decrease of cofilin-1 activity.
Silencing of cofilin-1 leads to defects in actin filament
disassembly and reduced migration activity in podocytes
To establish cofilin-1 was integral to actin dynamics in
podocytes, cofilin-1 expression was silenced with siRNA (Fig. 4A).
When we stained for actin fibers under normal culture conditions,
we did not observe any significant changes in actin morphology in
the cofilin-1 silenced cells (data not shown). To determine if
silencing of cofilin-1 expression affected actin cytoskeletal
recovery, we treated control silenced cells and cells treated with
cofilin-1 siRNA with cytochalasin D (Fig. 4B). When we
sequentially recovered the cells and stained for actin fibers, we
found accumulation of radial actin bundles in cofilin-1 silenced
cells eight hours after treatment with cytochalasin D. These results
suggested the presence of cofilin-1 enhanced actin depolymeriza-
tion and led to decreased formation of actin stress fibers as a
prerequisite for recovery and cellular spreading in culture.
Moreover, when we performed actin polymerization assays, we
found a significant enhancement of actin accumulation in the
cofilin-1 silenced podocytes (Fig.4C). Both findings indicated a
profound defect in actin filament disassembly. Without expression
of cofilin-1, the podocytes although initially characterized by small
cells with many extended filopodia compared to control cells,
began to spread and showed evidence of forming normal actin
stress fibers by 2 hours post cytochalasin D treatment. Control
cells did not demonstrate these characteristics until eight hours
post treatment. Since actin turnover is required for migration of
cells we wanted to test whether silencing of cofilin-1 would
interfere with podocyte migration behavior in culture. To examine
podocyte migration, we administered scrape wounds to control
and cofilin-1 silenced podocyte cultures. We determined cofilin-1
silenced podocytes migrated slower and covered the wounded area
significantly slower than control silenced cells (Fig. 4D). These data
indicated that cofilin-1 activity was required for normal actin
filament turnover and cellular migration activity in podocytes.
In diseases associated with foot process effacement,
cofilin-1 was inactivated and translocated to the nucleus
of podocytes
The AC family of proteins is regulated by phosphorylation of
serine 3. When serine 3 is phosphorylated, these proteins cannot
bind globular or filamentous actin and are considered inactive.
When serine 3 is dephosphorylated, these proteins are activated
and bind both forms of actin [17]. Numerous studies have
demonstrated that AC proteins are regulated by upstream stimuli
in various cell types [14]. We examined 100 glomerular cross
sections of five different human control samples and determined
phosphorylated cofilin-1 was absent in healthy, control patients
without proteinuria (Fig. 5A). Therefore, cofilin-1 is dephosphor-
ylated and active under normal homeostasis conditions (Fig. 5B).
In contrast, analysis of biopsies from patients with nephrotic
glomerular disease (7 cases of FSGS, 6 MCD and 8 MGN)
demonstrated p-cofilin-1 located to the nucleus in the majority of
podocytes. In the FSGS cases, the average nuclear p-cofilin
expression was 1161.62 (range: 3–21 positive podocyte nuclei,
n=101 examined glomerular cross sections). In MCD the average
p-cofilin-1 expression was 1060.72 (range: 3–19, n=83) and in
MGN the average p-cofilin expression was 1161.47 (range: 3–19,
n=77) (Fig. 5B). In summary, we did not observe a single
glomerulus in the normal state that contained podocytes with
inactive p-cofilin in their nucleus while in the diseased states we
did not observe a single glomerulus with podocytes negative for
inactive cofilin. These results are consistent with the hypothesis
that inactivation of cofilin-1 occurs in disease states in podocytes.
Discussion
Podocyte foot processes are highly dynamic cell extensions with
an actin-based contractile apparatus. Since the glomerular
capillary pressure constantly changes with blood pressure, it is
likely that the foot processes experience distension of the capillary
Cofilin-1 in Podocytes
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to assure a network of functional filtration slits [6,25]. In this study
we examined the role of cofilin-1, a member of the actin
depolymerizing factor/cofilin family of proteins, in regulation of
F-actin assembly and turnover in podocytes. These studies
demonstrated cofilin-1 plays an essential role in normal functions
of podocytes. Our findings are supported by the following lines of
evidence. We demonstrated for the first time, that cofilin-1 was
required for the integrity of the podocyte filtration barrier in vivo in
two models of cofilin-1 deficiency. The cofilin-1 mutant was
generated via a proviral insertion into the cofilin-1 gene. This
phenotype could be reproduced using a knockdown of cofilin-1
with morpholino techniques. In both systems we demonstrated
functionally and morphologically that without cofilin-1 normal
foot processes are not present. Instead the cofilin-1 knockdown
and the cofilin-1 mutation results in the typical effacement
Figure 2. Cofilin-1 is the dominant ADF/cofilin family isoform in murine and human podocytes. (A) Using a primary rabbit antibody to
cofilin, a diffuse distribution of cofilin throughout the cytoplasm was observed in both murine and human control podocytes (2A, red). In wildtype
murine and normal human glomeruli, expression of cofilin colocalized with synaptopodin, a podocyte specific marker (2A, merge white arrows, insert
enlarged 106). (B) Analysis of RNA lysates of conditionally immortalized murine and human podocytes demonstrated cofilin-1 is the dominant
isoform compared to cofilin-2 and ADF expression levels. The concentration of the cofilin-1 message is approximately 10 times higher than cofilin-2
and 3 times higher than ADF in murine podocytes and approximately 10 times higher than ADF in human podocytes, whereas cofilin-2 mRNA is
barely detectable in human podocytes. Murine and human podocyte ADF/cofilin isoform expression levels did not significantly differ between one
and ten days of differentiation.
doi:10.1371/journal.pone.0012626.g002
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similar to the podocyte effacement phenotype observed in human
disease states. We showed in murine and human cells in culture,
that cofilin-1 was the dominant isoform of the AC family of
proteins in podocytes and we clearly demonstrated cofilin-1
expression along with the podocyte specific marker synaptopodin
in murine and human tissues. This is well in line with the findings
of Vartiainen et al., who have demonstrated earlier that cofilin-1 and
ADF are the most abundant isoforms in the kidney [28].
Interestingly, when we examined human control tissues for
expression of inactivated, phosphorylated cofilin-1, we did not
detect any phosphorylated cofilin-1. In contrast in disease states we
detect a significant increase in p-cofilin expression. This indicates
the presence of inactive cofilin-1 coincides with high level
proteinuria and foot process effacement and could be interpreted
as indirect evidence that active cofilin-1 is required for normal
podocyte function.
When we exposed murine and human podocytes to TGF-b,w e
found that TGF-b stimulation led to an increase in cofilin-1
phosphorylation. This is particularly relevant since we and others
have described TGF-b as a causative factor for disease initiation
and progression of proteinuric diseases in mice and humans. TGF-
b activation is a well described pathomechanism in various
glomerular diseases with proinflammatory and profibrotic activity
and has direct proapoptotic effects on podocytes [8,26,27].
Therefore, it is tempting to speculate that cofilin-1-inactivation is
linked to proteinuria in different disease states with TGF-b
activation. On the other hand, stimulation with PMA induces a
strong activation response on cofilin-1. Moreover, baseline-
phosphorylation of cofilin-1 was detectable in resting unstimulated
podocytes in culture and cells can respond with more activation as
well as more inactivation. We presume that the regulation of
cofilin-1 activity is under autocrine control with the potential to
respond with more or less activation depending on the cellular
micromillieu and physiological context. Our data are supported by
functional in vitro experiments where we can demonstrate that
cofilin-1 activity is required for actin bundling and podocyte
motility. Numerous studies link AC proteins to the formation of
Figure 3. Treatment of cultured podocytes with PMA and TGF-b regulated cofilin-1 phosphorylation and activity. (A) Western blot
analysis using the p-cofilin specific antibody demonstrated cofilin-1 regulation through serine 3 phosphorylation in murine and human podocytes
treated with PMA and TGF-b. Phosphorylation profiles in response to 8 hours of treatment with TGF-b demonstrated a very strong increase in cofilin-
1 phosphorylation resulting in cofilin-1 inactivation in murine and human podocytes. In contrast treatment with PMA led to dephosphorylation and
activation of cofilin-1 in murine and human podocytes. GAPDH was probed as a protein loading control. (B) Densitometric summary of p-cofilin/
GAPDH ratios of three independent experiments.
doi:10.1371/journal.pone.0012626.g003
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ATP hydrolysis, increasing actin treadmilling, polymerization and
depolymerization of actin filaments, and filament severing.
Cellular protrusions, which are prerequisites for cell movement
and subsequent cell migration, result from newly polymerized
actin filaments pushing the cellular membrane forward. This
process has been observed in the formation of filopodia,
pseudopodia, lamellipodia and growth cones. These cellular
extensions are dynamic and can be observed during normal
development and morphogenesis, in the immune response of
lymphocytes, in metastasis of cancer cells, neuronal growth cones
and in response to wounding. Similar findings with diminished
Figure 4. Murine podocytes transfected with cofilin-1 siRNA recovered more rapidly from cytochalasin D treatment than control
cells and accumulated more actin, but have a reduced migration capability. (A) Western blot analysis of control and cofilin-1 siRNA
transfected cell extracts demonstrated cofilin-1 protein expression was silenced by siRNA transfection. (B) Both control and cofilin-1 siRNA cells
treated with cytochalasin were observed for recovery at 0, 1, 2 and 8 hours post treatment. At 0 and 1 hour time points, no discernible difference was
observed in the control and cofilin-1 siRNA treated cells. By 2 hours post treatment, the cytochalasin effects on the cofilin-1 siRNA treated cells was
diminished compared to the control siRNA cells. By 8 hours a significant difference in cell shape, size and cell spread was observed in the cofilin 1
siRNA treated cells compared to control cells. (C) Actin polymerization assay demonstrated an increased accumulation of actin fibers in podocytes in
the absence of cofilin-1 (red squares) compared to control silenced podocytes (green triangles). Pyrene Actin in the absence of cell lysates serves as
background control (black circles). (D) Control and cofilin-1 siRNA treated podocytes grown to confluence were wounded (0 hours) and their recovery
examined 24 hours later. Control siRNA podocytes migrated to fill in the wound region at a significantly faster rate than podocytes treated with
cofilin-1 siRNA.
doi:10.1371/journal.pone.0012626.g004
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amounts of actin fibers were published earlier in other mammalian
cells [29] and even a defective migration of cells in vivo has been
published earlier [30]. In our studies we demonstrated the essential
role of active cofilin in podocyte cell migration. When cofilin was
silenced in cultured podocytes with cofilin siRNA, the podocytes
response to healing after wounding was severely delayed compared
to the response of control cells to the wound. Since the cofilin
silenced podocytes did not extend filopodia similar to the control
cells, this suggested active cofilin was required for formation of
Figure 5. Phosphorylated cofilin-1 was increased in podocyte nuclei of patients suffering from FSGS, MCD and MGN. Glomeruli
recovered from patients with glomerular diseases, FSGS, MCD and MGN, were probed with the rabbit primary antibody to p-cofilin and goat primary
antibody to podocalyxin (PDX) and visualized using an Alexa488 labelled antibody raised against goat (green) and a Cy3-labelled secondary antibody
against rabbit (red). Podocytes in these diseased glomerular tissues demonstrated an increased incidence of phosphorylated cofilin-1 in their nuclei
(merged images 6DAPI). In contrast p-cofilin of normal control patients revealed no glomerular staining indicating that the cofilin-1 expressed in the
glomerulus under normal conditions is active and under disease-conditions is inactivated.
doi:10.1371/journal.pone.0012626.g005
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and formation of new actin filaments beneath of the plasma
membrane would be severely limited and could no longer put
forward pressure on the overlying membrane to protrude. Also, an
intact actin cytoskeleton would be required for formation of focal
contacts that are required to pull the cell forward. The
requirement of active cofilin in migration has been previously
demonstrated in Cos and MCF7 cells where lamellipodia
extensions in response to growth factors were reduced when
cofilin was inactivated [31] and in MRLn3 cells where maturation
of invadopodia were suppressed when cofilin was inhibited [32].
Thus, we hypothesize that the expression of phosphorylated
cofilin-1 in glomerular diseases suggests a reduced capacity of
podocytes to adapt to glomerular pressure differences. A higher
filtration pressure and distension of the capillary wall can not be
compensated and leads to proteinuria. Since proteinuric patients
are regularly treated with drugs reducing the glomerular filtration
pressure, this mechanism could partially explain the success of
these treatment regimens, which have been proven to reduce
proteinuria and are considered podocyte protective [33]. Recently,
Garg et al. described a podocyte specific mechanism of cofilin-1
activation. They demonstrated a nephrin induced cofilin dephos-
phorylation and found that the podocyte specific cofilin-1
knockout develops proteinuria [34].
In summary, we conclude that cofilin-1 is an essential regulator
for recycling of actin-filaments in podocytes to ensure the dynamic
nature of the foot processes. This could be the basis of a very
common mechanism in human proteinuric diseases leading to the
same phenotype, effacement and inability to form or maintain foot
processes.
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